Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Johnson & Johnson Vision Care is committed to creating life-long solutions to vision care needs. Since the ACUVUE Brand made its debut in 1987 as the world’s first disposable soft contact lens, the company has repeatedly brought quality, scientific and innovative advancements to the industry. Headquartered in Jacksonville, Florida, the company has some 3,000 employees worldwide.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Valspar Industries, Inc. manufactures industrial coatings and specialty chemical products. The company was founded on December 5, 1888 and is headquartered in Indianapolis, IN.

Beijing Ruiyibo Technology Co., Ltd., established on 2021-01-05, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Machinery and Equipment Leasing(Car rental not included);sell electronics,Medical DeviceΙ,Class II(In addition to electronic products,Clothing and other physical stores);Medical Research and Experimental Development;Conference Services;Sales of Class III Medical Devices(In addition to electronic products,Clothing and other physical stores).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Guangzhou Baiyunshan Kampo Modern Pharmaceutical Co., Ltd., established on 1998-09-24, Business scope includes drug retail;egg processing;Health food manufacturing;Food additive manufacturing;Solid beverage manufacturing;Manufacturing of chemical raw materials;Chinese herbal medicine processing;Chinese patent medicine production;Wholesale Prepackaged Food;Dairy retail;Manufacturing of chemical preparations;Health food wholesale(Specific business items are<food business license>prevail);Manufacture of formula food for special medical purpose;Sales of formula foods for special medical purposes;Commodity wholesale trade(Except for licensed and approved products);Technology Import and Export;Wholesale of cosmetics and hygiene products;Wholesale of chemical products(Excluding hazardous chemicals);Retailing of cosmetics and hygiene products;software development;Information Technology Consulting Services;Medical Research and Experimental Development;Food Science and Technology Research Services;electronic,Communication and Automatic Control Technology Research,to develop;computer technology development,Technical Services;Chemical product testing service;drug development;computer retail;Computer Parts Retail;General machinery and equipment retail;Commodity retail trade(Except for licensed and approved products);Import and export(Excluding franchised products);Realtor;Operation of non-licensed medical devices;Research and development of formula food for special medical purpose;

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Zhengzhou Lydia Pharmaceutical Technology Co., Ltd., established on 2015-11-20, Business scope includes medical technology development,technology transfer,Technical Consulting and Technical Services;Chemical technology development,technology transfer,Technical Consulting and Technical Services;Sales:Chemical Products(flammable,Explosive,Precursor,Excluding hazardous chemicals),Instrumentation,ink,building materials;data processing services;Development of computer software and hardware technology,technical consulting,Transfers and Services;software development;Computer System Integration Services.

Jinan Shuaihua Pharmaceutical Technology Co., Ltd., established on 2005-08-17, Business scope includes licensed business items:none;General operating items:Development of medical technology,technology transfer,Technical Advisory Services.(Except for projects that have not obtained special permits)(If the above business scope involves the special franchise regulations of the state, the regulations shall be followed.)

AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

Beijing Dekerui Pharmaceutical Technology Co., Ltd., established on 2006-07-24, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Cosmetics Wholesale;Cosmetics Retail;Machinery sales;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Industrial Design Services;Socioeconomic Advisory Services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Drug Wholesale;Drug retail;Pharmaceutical commissioned production;liquor business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

MOLOGEN AG engages in the research and clinical development of drugs in the fields of oncology and infectious diseases. Its products include lefitolimod and its follow-up molecules EnanDIM, and cell-based therapeutic vaccine MGN1601. The company was founded by Matthias P. Schlichting and Burghardt Wittig on January 14, 1998 and is headquartered in Berlin, Germany.

Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology and cardiology. Trophos is a fully integrated clinical stage company with a pipeline of original molecules in development for the motoneuron diseases amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and spinal muscular atrophy (SMA), chemotherapy-induced peripheral neuropathy, cardiac ischemia-reperfusion injury and other neurological conditions.

Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.

Hainan Periwinkle Pharmaceutical Co., Ltd., established on 2005-08-18, Business scope includes raw materials(vincristine sulfate)Production,Processing and sales;Technology development of pharmaceuticals and pharmaceutical intermediates,Technical Advisory Services,technology transfer,Market Consulting Services,R & D.(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Shandong Lanjin Biological Engineering Co., Ltd., established on 2001-12-06, The scope of business includes the research and development of pharmaceuticals,technology transfer,consultation service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The validity period is subject to the license).